kabutan

STELLA PHARMA, The Current Fiscal Year's Ordinary Loss to Widen

Fri May 9, 2025 2:00 pm JST Earnings

4888 STELLA PHARMA CORPORATION 【J-GAAP】

Earnings Report

STELLA PHARMA CORPORATION <4888> [TSE Growth] announced its financial results in the afternoon session on May 9th (14:00). The ordinary loss (non-consolidated) for the fiscal year ending March 2025 was loss of 137 million yen, a reduction in the deficit compared to loss of 137 million yen in the previous term. For the fiscal year ending March 2026, the ordinary loss is expected to be loss of 345 million yen. This will mark the eighth consecutive term of losses.

In the most recent three-month period, from January to March (4Q), the ordinary profit/loss turned to a profit of 234 million yen (compared to a loss of 294 million yen in the same period last year). The operating profit/loss margin drastically improved from -426.1% in the same period last year to 40.3%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 229 -806 -775 -778 -27.0 0 May 9, 2023 J-GAAP
Mar, 2024 269 -760 -760 -763 -24.7 0 May 10, 2024 J-GAAP
Mar, 2025 961 -90 -137 -140 -4.2 0 May 9, 2025 J-GAAP
YoY +257.2% +88.2% +82.0% +81.7% +82.9%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 930 -252 -257 -260 -7.6 0 May 10, 2024 J-GAAP
Mar, 2025 Results 961 -90 -137 -140 -4.2 0 May 9, 2025 J-GAAP
Revision Rate +3.3% +64.3% +46.7% +46.2% +44.8%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 169 -269 -267 -268 -8.2 0 Nov 8, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 0 May 9, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 269 -760 -760 -763 -24.7 0 May 10, 2024 J-GAAP
Mar, 2025 961 -90 -137 -140 -4.2 0 May 9, 2025 J-GAAP
Mar, 2026 Guidance 1,007 -348 -345 -348 -10.2 0 May 9, 2025 J-GAAP
YoY +4.8% -286.7% -151.8% -148.6% -142.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 69 -294 -294 -294 -9.5 -426.1 May 10, 2024 J-GAAP
Apr - Jun, 2024 61 -166 -161 -161 -5.1 -272.1 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 108 -103 -106 -107 -3.3 -95.4 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 85 -106 -104 -105 -3.2 -124.7 Feb 12, 2025 J-GAAP
Jan - Mar, 2025 707 285 234 233 7.0 40.3 May 9, 2025 J-GAAP
YoY +924.6% － － － －

Related Articles